首页> 外文期刊>Journal of Medicinal Chemistry >Design, Synthesis, and in Vitro and in Vivo Evaluation of Ouabain Analogues as Potent and Selective Na,K-ATPase α4 Isoform Inhibitors for Male Contraception
【24h】

Design, Synthesis, and in Vitro and in Vivo Evaluation of Ouabain Analogues as Potent and Selective Na,K-ATPase α4 Isoform Inhibitors for Male Contraception

机译:对奥巴宾类似物的设计,合成和体外和体内评价为有效和选择性Na,K-ATP酶α4同种型抑制剂用于男性避孕药

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Na,K-ATPase α4 is a testis-specific plasma membrane Na~(+) and K~(+) transporter expressed in sperm flagellum. Deletion of Na,K-ATPase α4 in male mice results in complete infertility, making it an attractive target for male contraception. Na,K-ATPase α4 is characterized by a high affinity for the cardiac glycoside ouabain. With the goal of discovering selective inhibitors of the Na,K-ATPase α4 and of sperm function, ouabain derivatives were modified at the glycone (C3) and the lactone (C17) domains. Ouabagenin analogue 25 , carrying a benzyltriazole moiety at C17, is a picomolar inhibitor of Na,K-ATPase α4, with an outstanding α4 isoform selectivity profile. Moreover, compound 25 decreased sperm motility in vitro and in vivo and affected sperm membrane potential, intracellular Ca~(2+), pH, and hypermotility. These results proved that the new ouabagenin triazole analogue is an effective and selective inhibitor of Na,K-ATPase α4 and sperm function.
机译:Na,K-ATP酶α4是睾丸特异性血浆膜Na〜(+)和K〜(+)转运蛋白,其在精子鞭毛中表达。 在雄性小鼠中缺失Na,K-ATP酶α4导致完全不孕,使其成为男性避孕的有吸引力的目标。 Na,K-ATP酶α4的特征在于对心脏糖苷Ouabain的高亲和力。 通过发现Na,K-ATP酶α4和精子功能的选择性抑制剂的目的,在烯酮(C3)和内酯(C17)结构域的橡胶衍生物被修饰。 在C17处携带苄基三唑部分的Ouabagenin类似物25是Na,K-ATP酶α4的皮摩尔抑制剂,具有出色的α4同种型选择性曲线。 此外,化合物25在体外和体内的精子活性降低,并且影响精子膜电位,细胞内Ca〜(2+),pH和高温性。 这些结果证明,新的Ouabagenin三唑类似物是Na,K-ATP酶α4和精子功能的有效和选择性抑制剂。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2018年第5期|共21页
  • 作者单位

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development College of Pharmacy University of Minnesota Minneapolis Minnesota 55414 United States;

    Department of Molecular and Integrative Physiology University of Kansas Medical Center Kansas City Kansas 66160 United States;

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development College of Pharmacy University of Minnesota Minneapolis Minnesota 55414 United States;

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development College of Pharmacy University of Minnesota Minneapolis Minnesota 55414 United States;

    Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development College of Pharmacy University of Minnesota Minneapolis Minnesota 55414 United States;

    Department of Molecular and Integrative Physiology University of Kansas Medical Center Kansas City Kansas 66160 United States;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号